Retrospective Data Analysis in Crohn's Disease

Retrospective Data Analysis of Newly Diagnosed Crohn's Disease Patients in Gastroenterological Surgeries

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01363427

Acronym

Crohn 2

Enrollment

161

Registered

2011-06-01

Start date

2007-03-31

Completion date

2010-07-31

Last updated

2011-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn's Disease

Brief summary

The purpose of this study is to identify prognostic parameters about efficacy of Mesalazine in recently diagnosed patients with Morbus Crohn by retrospective data collection.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* therapeutic need according to SPC * written informed consent

Design outcomes

Primary

Measure	Time frame
Response to Mesalazine: measured by time to step up therapy	12 to 48 months

Secondary

Measure	Time frame	Description
Identification and characterisation of the responding sub-population	12 to 48 months	measured by: (a) Age at diagnosis, (b) Proportion of patients with minor endoscopic lesions, (c) Lack of severe mucosal lesions (Adapted Rutgeerts Score \< 2)

Countries

Germany

Outcome results